Clinical Trials Directory

Trials / Completed

CompletedNCT00901719

Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

Investigating the Interaction of Apelin and Systemic Angiotensin II Peripheral Resistance Vessels and Systemic Haemodynamics in Vivo in Man

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
18 Months – 85 Years
Healthy volunteers
Accepted

Summary

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease. Two of the main actions of apelin are to increase the pumping ability of the heart and cause blood vessels to relax. The investigators wish to assess if these actions are altered in the setting of normal renin-angiotensin activation and increased renin-angiotensin activity.

Conditions

Interventions

TypeNameDescription
DRUGApelinUsing the technique of venous occlusive plethysmography subjects will receive three intrabrachial apelin infusions at 0.3, 1.0 and 3.0 nanomol/ml.
DRUGAcetylcholineUsing the technique of venous occlusive plethysmography subjects will receive three intrabrachial acetylcholine infusions at 5, 10 and 20 microg/min
DRUGSodium nitroprussideUsing the technique of venous occlusive plethysmography subjects will receive three intrabrachial acetylcholine infusions at 1, 2 and 4 microg/min
DRUGSystemic apelin infusionFollowing plethysmography patients will receive systemic infusion of (Pry)Apelin-13 (30, 100 and 300 nmol/min) for 5 mins cardiac output, blood pressure, heart rate and systemic vascular resistance will be measured at 5-min intervals.

Timeline

Start date
2010-04-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2009-05-14
Last updated
2010-08-10

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00901719. Inclusion in this directory is not an endorsement.